Real-world performance of iFIND-TBR for rapid detection of Mycobacterium tuberculosis and rifampicin resistance in China
The iFIND assay is a rapid and automated assay with sensitivity and specificity comparable to Xpert for early TB diagnosis and drug resistance screening, making it particularly suitable for implementation in primary healthcare settings and general hospitals.
Authors
- Y Q Chen
- Yuan Zhao (ORCID: https://orcid.org/0000-0003-3799-489X)
- Ruida Xing (ORCID: https://orcid.org/0000-0001-9696-0214)
- Hui Xia
- Lixia Zhang (ORCID: https://orcid.org/0000-0002-5288-0797)
- Yajie Guo
- Feina Li
- Jiaojian Zeng
- Yingzi Ma
- Lin Huang
- Xichao Ou
- Yan Li
- Bing Zhao
- Huiwen Zheng
Institutions
- Chinese Center For Disease Control and Prevention (CN)
- Taiwan Centers for Disease Control (TW)
- Beijing Children’s Hospital (CN)
- National Institute for Communicable Disease Control and Prevention (CN)
- Tianjin haihe hospital (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2026-02-12
- DOI
- https://doi.org/10.3389/fmicb.2026.1757837
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Beijing Municipal Health Commission